| Pharmaceutical active ingredients: |
| Pentaerithrityl Tetranitrate |
| Available forms, composition and doses of Deltrate 20: |
| N / A |
| Deltrate 20 medical category: |
| Human:Vasodilating agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C01DA05 - Pentaerithrityl Tetranitrate |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Angitet | Pentaerithrityl Tetranitrate | Unidentified Pharmaceutical Company |
| Antora | Pentaerithrityl Tetranitrate | Unidentified Pharmaceutical Company |
| Arcotrate | Pentaerithrityl Tetranitrate | Unidentified Pharmaceutical Company |
| Baritrate | Pentaerithrityl Tetranitrate | Unidentified Pharmaceutical Company |
| Cardiacap | Pentaerithrityl Tetranitrate | Consolidated Chemicals |
| Dilcoran | Pentaerithrityl Tetranitrate | Alpharma; Parke-Davis |
| Dipentrate | Pentaerithrityl Tetranitrate | Unidentified Pharmaceutical Company |
| Duotrate | Pentaerithrityl Tetranitrate | King Pharmaceuticals |
| Erinit | Pentaerithrityl Tetranitrate | Unidentified Pharmaceutical Company |
| Erynit | Pentaerithrityl Tetranitrate | Biosynthesis |